Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2
Vanessa Monteil, Hyesoo Kwon, Patricia Prado, Astrid Hagelkrüys, Reiner Wimmer, Martin Ståhl, Alexandra Leopoldi, Elena Garreta, Carmen Hurtado del Pozo, Felipe Prósper, Juan P. Romero, Gerald Wirnsberger, Haibo Zhang, Arthur S. Slutsky, Ryan Conder, Núria Montserrat, Alì Mirazimi, Josef Penninger
Topics & Concepts
BiologyVero cellSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)VirologyAngiotensin-converting enzyme 2CoronavirusRecombinant DNAReceptorCoronavirus disease 2019 (COVID-19)LungOrganoidBetacoronavirusHEK 293 cells2019-20 coronavirus outbreakVirusImmunologyGeneCell biologyInternal medicineMedicineGeneticsOutbreakDiseaseInfectious disease (medical specialty)SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research Studies